Arkolith/Insider Trading/SPRO/Form 4

Rajavelu Esther

See RemarksSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Nov 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$95K
Net Open-Market Flow
-$95K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Sell(S)40K$2.37$95K869K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-278370) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML